Anti-Inflammatory Therapeutics Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the anti-inflammatory therapeutics market right now?
The market size for anti-inflammatory therapeutics has shown consistent growth over the past years. The market is expected to expand from $114.71 billion in 2024 to $118.44 billion in 2025, showcasing a compound annual growth rate (CAGR) of 3.3%. The escalation during the historical period was influenced by factors such as the surge in chronic illnesses, aging demographic, heightened awareness, and government-driven initiatives.
How fast Is the anti-inflammatory therapeutics market expected to grow, and what’s its future value?
The market size of anti-inflammatory therapeutics is predicted to witness considerable expansion in the upcoming years, reaching a figure of $144.05 billion in 2029 with a compound annual growth rate (CAGR) of 5.0%. The anticipated progression in this timeframe can be ascribed to the emergence of innovative therapies, a surge in healthcare spending, attention towards rare diseases, and developments in biologics and biosimilars. Key advancements projected for this period include progress in immunotherapy, the involvement of artificial intelligence (AI) and machine learning (ML) in drug discovery, and the broadening of indications.
Get your anti-inflammatory therapeutics market report here!
What are the leading drivers of growth in the anti-inflammatory therapeutics market?
The growth of the anti-inflammatory therapeutics market is likely to be fueled by the escalating prevalence of inflammatory bowel disease. This chronic condition involves inflammation of the gastrointestinal tract, with anti-inflammatory therapeutics proving vital in treating conditions like Crohn’s disease. They help decrease inflammation, control disease symptoms, and lower the need for surgical intervention. The University Press of the University of Oxford reported in July 2023 that the incidence rate of inflammatory bowel disease (IBD) was 10.9 per 100,000 person-years and the prevalence rate was 721 per 100,000 individuals. Such mounting prevalence rates of inflammatory bowel disease (IBD) signpost a growth trajectory for the anti-inflammatory therapeutics market. Anticipated increases in the prevalence of autoimmune disorders also prompts optimism for continued growth in the anti-inflammatory therapeutics market. Autoimmune disorders constitute medical conditions where the immune system erroneously attacks the body’s healthy cells and tissues it is designed to protect against harmful invaders like bacteria and viruses. Treatment for these disorders typically involves anti-inflammatory therapeutics designed to reduce inflammation, regulate the immune system’s hyperactive response, and relieve associated symptoms. For example, the Guardian Media Group predicted in January 2022 that 4 million people in the UK will experience autoimmune disorders, with global rates projected to increase by 3-9% annually. Furthermore, the University of Oxford reported in May 2023 that 10% of the global population is affected by autoimmune disorders. With these statistics in mind, the increasing prevalence of autoimmune disorders is instrumental in propelling the anti-inflammatory therapeutics market’s growth.
What are the key segments defining the anti-inflammatory therapeutics market?
The anti-inflammatory therapeutics market covered in this report is segmented –
1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics
2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Distribution
Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen
2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone
3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Janus Kinase (JAK) Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp
Who are the key players steering the development of the anti-inflammatory therapeutics market?
Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.
What emerging trends are influencing the growth of the anti-inflammatory therapeutics market?
The anti-inflammatory therapeutics market is seeing the introduction of novel drugs by leading companies, solidifying their market stance. For example, Regeneron Pharmaceuticals Inc., an American biotechnology corporation, and Sanofi, a French pharmaceutical and healthcare enterprise, deployed Kevzara (sarilumab) in February 2023. This anti-inflammatory biologic, unique in its recommendations, is for adults with polymyalgia rheumatic (PMR), a type of inflammatory rheumatic disease, who have not appropriately responded to corticosteroids or who cannot tolerate corticosteroid tapering.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12861
Which regions are most influential in expanding the anti-inflammatory therapeutics market?
North America was the largest region in the anti-inflammatory therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Network Centric Warfare Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/network-centric-warfare-global-market-report
Artificial Intelligence In Modern Warfare Global Market Report 2024
Submarine Combat System Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/submarine-combat-system-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
